The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kompella Lopa Mudra
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kompella Lopa Mudra, a promoter group member of Vivo Bio Tech Limited, has disclosed an acquisition of 1,60,000 equity shares under SEBI Regulation 29(2). The shares were allotted on April 17, 2025, through the conversion of warrants that were earlier issued on a preferential basis. Before this event, her entire holding of 6,00,000 shares (3.43% of voting capital) was in the form of convertible warrants. After conversion, 1,60,000 shares are held directly as equity (0.89% of voting capital) and 4,40,000 remain as warrants, keeping the total holding steady at 6,00,000 shares (3.35% of voting capital, 2.54% of diluted capital). The company's equity capital rose marginally to 1,79,24,816 shares as part of this allotment.
This is a routine disclosure triggered by the conversion of pre-existing warrants, not fresh open-market buying, so it is unlikely to move the stock price. It reflects continued promoter group engagement with the company but does not change the promoter's economic stake.